Edwards Lifesciences valuation

EW · NYSE · USD

Compare Edwards Lifesciences
$105.43Change from previous close: −1.57%Absolute change: −$1.68

Close · November 17, 2026

Valuation

The P/E ratio is 61.6. The average price target of 27 analysts is $113.39.

Data as of November 17, 2026

Edwards Lifesciences compared with similar companies

Edwards Lifesciences's P/E (trailing 12 months): 61.6, +102% against the median of a group of 11 similar companies (30.5).

Edwards Lifesciences's metrics compared with similar companies
MetricEdwards LifesciencesMedian25th–75th percentileBand
P/E (trailing 12 months)61.630.524.4 – 36.6High
Forward P/E31.618.415.4 – 23.4High
EV/EBITDA27.616.114.0 – 19.3High
Price/book5.683.652.90 – 6.03Middle
Price/sales9.233.863.08 – 5.23High
Gross margin78.0%65.7%60.3% – 68.7%High
Operating margin28.8%19.2%16.2% – 22.0%High
Net margin15.3%13.4%10.0% – 14.6%High
ROE9.3%11.6%10.0% – 18.0%Low
Debt/equity0.060.550.37 – 0.63Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Edwards Lifesciences: valuation over time

On the latest fiscal year's earnings (2025), Edwards Lifesciences's P/E today is 58.4, above the median of its last 8 fiscal years (45.9; between 10.6 and 70.2 from 2018 to 2025). Relative to earnings, the stock costs more than it used to.

Edwards Lifesciences P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$85.25$1.8346.6
2024$74.03$6.9710.6
2023$76.25$2.3033.2
2022$74.61$2.4430.6
2021$129.55$2.3854.4
2020$91.23$1.3070.2
2019$77.76$1.6447.4
2018$51.06$1.1345.2

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$61.59B
Enterprise value
$57.75B
PEG
2.36
EV/revenue
8.65

Profitability and growth

ROA
8.8%
Revenue growth (year over year)
10.5%
Earnings growth (year over year)
6.7%

Financial health

Total cash
$4.64B
Total debt
$704.5M
Current ratio
4.60
Quick ratio
3.54

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$113.39
Median price target
$115.00
High price target
$126.00
Low price target
$84.00
Analysts with a price target
27
Consensus
Buy
Forward EPS
$3.39
EPS estimate, current year
$3.01

Shares and trading

Beta
0.83
Average volume
3.82M
Shares outstanding
575M
Float
573.22M
Institutional ownership
95.2%
Insider ownership
0.4%
Short interest (% of float)
1.9%
Short ratio (days)
2.58